Annual FCF
-$14.26 M
-$7.36 M-106.74%
31 December 2023
Summary:
Trinity Biotech annual free cash flow is currently -$14.26 million, with the most recent change of -$7.36 million (-106.74%) on 31 December 2023. During the last 3 years, it has fallen by -$27.82 million (-205.19%). TRIB annual FCF is now -201.46% below its all-time high of $14.06 million, reached on 31 December 2010.TRIB Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly FCF
-$6.32 M
-$2.05 M-48.14%
30 September 2024
Summary:
Trinity Biotech quarterly free cash flow is currently -$6.32 million, with the most recent change of -$2.05 million (-48.14%) on 30 September 2024. Over the past year, it has dropped by -$1.04 million (-19.63%). TRIB quarterly FCF is now -150.29% below its all-time high of $12.57 million, reached on 31 December 2020.TRIB Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM FCF
-$15.52 M
-$1.04 M-7.16%
30 September 2024
Summary:
Trinity Biotech TTM free cash flow is currently -$15.52 million, with the most recent change of -$1.04 million (-7.16%) on 30 September 2024. Over the past year, it has dropped by -$2.60 million (-20.13%). TRIB TTM FCF is now -174.27% below its all-time high of $20.89 million, reached on 31 March 2021.TRIB TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TRIB Free Cash Flow Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -106.7% | -19.6% | -20.1% |
| 3 y3 years | -205.2% | -2312.6% | -201.7% |
| 5 y5 years | -40.3% | -346.7% | -144.2% |
TRIB Free Cash Flow High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -205.2% | at low | -440.8% | at low | -201.7% | at low |
| 5 y | 5 years | -205.2% | at low | -150.3% | at low | -174.3% | at low |
| alltime | all time | -201.5% | +1.9% | -150.3% | +32.1% | -174.3% | +6.4% |
Trinity Biotech Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$6.32 M(+48.1%) | -$15.52 M(+7.2%) |
| June 2024 | - | -$4.27 M(-0.4%) | -$14.48 M(-4.7%) |
| Mar 2024 | - | -$4.28 M(+559.8%) | -$15.20 M(+6.6%) |
| Dec 2023 | -$14.26 M(+106.7%) | -$649.00 K(-87.7%) | -$14.26 M(+10.4%) |
| Sept 2023 | - | -$5.28 M(+6.1%) | -$12.92 M(+56.0%) |
| June 2023 | - | -$4.98 M(+48.8%) | -$8.28 M(+17.7%) |
| Mar 2023 | - | -$3.35 M(-582.3%) | -$7.04 M(+2.0%) |
| Dec 2022 | -$6.90 M(-251.7%) | $694.00 K(-207.1%) | -$6.90 M(+20.2%) |
| Sept 2022 | - | -$648.00 K(-82.7%) | -$5.74 M(+7.2%) |
| June 2022 | - | -$3.74 M(+16.5%) | -$5.35 M(+189.7%) |
| Mar 2022 | - | -$3.21 M(-272.9%) | -$1.85 M(-140.6%) |
| Dec 2021 | $4.55 M(-66.5%) | $1.85 M(-808.0%) | $4.55 M(-70.2%) |
| Sept 2021 | - | -$262.00 K(+12.9%) | $15.26 M(-23.2%) |
| June 2021 | - | -$232.00 K(-107.3%) | $19.86 M(-4.9%) |
| Mar 2021 | - | $3.19 M(-74.7%) | $20.89 M(+54.1%) |
| Dec 2020 | $13.56 M(-310.6%) | $12.57 M(+189.6%) | $13.56 M(-700.1%) |
| Sept 2020 | - | $4.34 M(+442.5%) | -$2.26 M(-71.8%) |
| June 2020 | - | $800.00 K(-119.3%) | -$8.01 M(+15.4%) |
| Mar 2020 | - | -$4.15 M(+27.9%) | -$6.95 M(+7.9%) |
| Dec 2019 | -$6.44 M(-36.7%) | -$3.25 M(+129.5%) | -$6.44 M(+1.3%) |
| Sept 2019 | - | -$1.42 M(-175.7%) | -$6.36 M(-55.4%) |
| June 2019 | - | $1.87 M(-151.3%) | -$14.25 M(+35.4%) |
| Mar 2019 | - | -$3.64 M(+15.0%) | -$10.53 M(+3.6%) |
| Dec 2018 | -$10.16 M(+46.6%) | -$3.17 M(-66.0%) | -$10.16 M(+1.7%) |
| Sept 2018 | - | -$9.31 M(-266.5%) | -$10.00 M(+2848.7%) |
| June 2018 | - | $5.59 M(-270.7%) | -$339.00 K(-94.0%) |
| Mar 2018 | - | -$3.28 M(+9.3%) | -$5.69 M(-18.0%) |
| Dec 2017 | -$6.93 M(-40.5%) | -$3.00 M(-972.1%) | -$6.93 M(+3.4%) |
| Sept 2017 | - | $344.00 K(+38.7%) | -$6.70 M(-7.1%) |
| June 2017 | - | $248.00 K(-105.5%) | -$7.21 M(-41.7%) |
| Mar 2017 | - | -$4.52 M(+63.2%) | -$12.37 M(+6.2%) |
| Dec 2016 | -$11.65 M(-19.9%) | -$2.77 M(+1539.6%) | -$11.65 M(-11.3%) |
| Sept 2016 | - | -$169.00 K(-96.6%) | -$13.13 M(-4.0%) |
| June 2016 | - | -$4.91 M(+29.3%) | -$13.67 M(-8.7%) |
| Mar 2016 | - | -$3.80 M(-10.7%) | -$14.98 M(+3.0%) |
| Dec 2015 | -$14.54 M(+24.3%) | -$4.25 M(+496.6%) | -$14.54 M(+6.6%) |
| Sept 2015 | - | -$713.00 K(-88.5%) | -$13.65 M(-3.3%) |
| June 2015 | - | -$6.22 M(+85.2%) | -$14.11 M(+30.7%) |
| Mar 2015 | - | -$3.36 M(-0.1%) | -$10.79 M(-7.7%) |
| Dec 2014 | -$11.70 M | -$3.36 M(+186.1%) | -$11.70 M(-29.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2014 | - | -$1.17 M(-59.6%) | -$16.51 M(-0.4%) |
| June 2014 | - | -$2.90 M(-31.8%) | -$16.57 M(+2.1%) |
| Mar 2014 | - | -$4.26 M(-47.9%) | -$16.23 M(+17.4%) |
| Dec 2013 | -$13.82 M(-396.2%) | -$8.18 M(+563.1%) | -$13.82 M(+116.8%) |
| Sept 2013 | - | -$1.23 M(-51.8%) | -$6.38 M(+97.8%) |
| June 2013 | - | -$2.56 M(+38.1%) | -$3.22 M(-325.2%) |
| Mar 2013 | - | -$1.85 M(+153.0%) | $1.43 M(-69.3%) |
| Dec 2012 | $4.67 M(-58.4%) | -$732.00 K(-138.1%) | $4.67 M(-30.2%) |
| Sept 2012 | - | $1.92 M(-8.4%) | $6.69 M(-14.4%) |
| June 2012 | - | $2.10 M(+51.7%) | $7.81 M(-10.4%) |
| Mar 2012 | - | $1.38 M(+7.1%) | $8.72 M(-22.3%) |
| Dec 2011 | $11.22 M(-20.2%) | $1.29 M(-57.6%) | $11.22 M(+35.6%) |
| Sept 2011 | - | $3.04 M(+1.3%) | $8.27 M(-40.7%) |
| June 2011 | - | $3.00 M(-22.7%) | $13.94 M(+7.0%) |
| Mar 2011 | - | $3.89 M(-334.5%) | $13.04 M(-7.3%) |
| Dec 2010 | $14.06 M(+238.9%) | -$1.66 M(-119.0%) | $14.06 M(-12.1%) |
| Sept 2010 | - | $8.71 M(+315.6%) | $15.99 M(+70.1%) |
| June 2010 | - | $2.10 M(-57.3%) | $9.40 M(-1.1%) |
| Mar 2010 | - | $4.91 M(+1690.9%) | $9.50 M(+129.1%) |
| Dec 2009 | $4.15 M(-311.1%) | $274.00 K(-87.1%) | $4.15 M(+7.1%) |
| Sept 2009 | - | $2.12 M(-3.7%) | $3.87 M(+121.0%) |
| June 2009 | - | $2.20 M(-590.4%) | $1.75 M(-259.8%) |
| Mar 2009 | - | -$449.00 K(-30.7%) | -$1.10 M(-47.5%) |
| Dec 2008 | -$1.97 M(+157.2%) | - | - |
| June 2008 | - | -$648.00 K(-55.1%) | -$2.09 M(+44.9%) |
| Mar 2008 | - | -$1.44 M | -$1.44 M |
| Dec 2007 | -$764.00 K(-78.0%) | - | - |
| Dec 2006 | -$3.47 M(-167.1%) | - | - |
| Dec 2005 | $5.17 M(-174.5%) | - | - |
| Dec 2004 | -$6.94 M(+2665.7%) | - | - |
| Dec 2003 | -$251.00 K(-2124.2%) | - | - |
| Dec 2002 | $12.40 K(-99.7%) | - | - |
| Dec 2001 | $3.81 M(+106.2%) | - | - |
| Dec 2000 | $1.85 M(-22.2%) | - | - |
| Dec 1999 | $2.38 M(-162.5%) | - | - |
| Dec 1998 | -$3.80 M(-60.0%) | - | - |
| Dec 1997 | -$9.50 M(+55.7%) | - | - |
| Dec 1996 | -$6.10 M(+577.8%) | - | - |
| Dec 1995 | -$900.00 K(-71.9%) | - | - |
| Dec 1994 | -$3.20 M(0.0%) | - | - |
| Feb 1994 | -$3.20 M | - | - |
FAQ
- What is Trinity Biotech annual free cash flow?
- What is the all time high annual FCF for Trinity Biotech?
- What is Trinity Biotech annual FCF year-on-year change?
- What is Trinity Biotech quarterly free cash flow?
- What is the all time high quarterly FCF for Trinity Biotech?
- What is Trinity Biotech quarterly FCF year-on-year change?
- What is Trinity Biotech TTM free cash flow?
- What is the all time high TTM FCF for Trinity Biotech?
- What is Trinity Biotech TTM FCF year-on-year change?
What is Trinity Biotech annual free cash flow?
The current annual FCF of TRIB is -$14.26 M
What is the all time high annual FCF for Trinity Biotech?
Trinity Biotech all-time high annual free cash flow is $14.06 M
What is Trinity Biotech annual FCF year-on-year change?
Over the past year, TRIB annual free cash flow has changed by -$7.36 M (-106.74%)
What is Trinity Biotech quarterly free cash flow?
The current quarterly FCF of TRIB is -$6.32 M
What is the all time high quarterly FCF for Trinity Biotech?
Trinity Biotech all-time high quarterly free cash flow is $12.57 M
What is Trinity Biotech quarterly FCF year-on-year change?
Over the past year, TRIB quarterly free cash flow has changed by -$1.04 M (-19.63%)
What is Trinity Biotech TTM free cash flow?
The current TTM FCF of TRIB is -$15.52 M
What is the all time high TTM FCF for Trinity Biotech?
Trinity Biotech all-time high TTM free cash flow is $20.89 M
What is Trinity Biotech TTM FCF year-on-year change?
Over the past year, TRIB TTM free cash flow has changed by -$2.60 M (-20.13%)